Abstract
• Phycocyanin inhibits the growth of NSCLC cells. • Phycocyanin induces autophagy and autophagy flux in NSCLC cells. • AMPK signaling pathway activation is involved in phycocyanin-treated lung cancer cells. • Phycocyanin attenuated viability of multiple lung cancer cells through promoting autophagy. Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide. Phycocyanin, a type of marine food additives, has been reported to exert antineoplastic effects in NSCLC. The aim of this study was to investigate roles of autophagy in the anticancer process of phycocyanin in NSCLC. Results showed that phycocyanin increased LC3-II/LC3-I ratio and decreased p62 level of NSCLC cells in a dose- and time-dependent manner. Laser scanning confocal observation of autophagic LC3 puncta showed phycocyanin promotes autophagy flux of NSCLC cells. In addition, AMPK signaling was activated upon phycocyanin treatment. Strikingly, phycocyanin was shown to synergistically affect the autophagy of cells with rapamycin and chloroquine, thus concertedly inhibiting the viabilities of NSCLC cells. These results indicated that the antineoplastic effect of phycocyanin could be attributed to the activated autophagy and AMPK signaling pathway. Thus, targeting autophagy could be a promising way to improve NSCLC though phycocyanin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.